These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 10430759)

  • 1. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.
    Rosengart TK; Lee LY; Patel SR; Sanborn TA; Parikh M; Bergman GW; Hachamovitch R; Szulc M; Kligfield PD; Okin PM; Hahn RT; Devereux RB; Post MR; Hackett NR; Foster T; Grasso TM; Lesser ML; Isom OW; Crystal RG
    Circulation; 1999 Aug; 100(5):468-74. PubMed ID: 10430759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-month assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA.
    Rosengart TK; Lee LY; Patel SR; Kligfield PD; Okin PM; Hackett NR; Isom OW; Crystal RG
    Ann Surg; 1999 Oct; 230(4):466-70; discussion 470-2. PubMed ID: 10522716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121.
    Lee LY; Patel SR; Hackett NR; Mack CA; Polce DR; El-Sawy T; Hachamovitch R; Zanzonico P; Sanborn TA; Parikh M; Isom OW; Crystal RG; Rosengart TK
    Ann Thorac Surg; 2000 Jan; 69(1):14-23; discussion 23-4. PubMed ID: 10654479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121.
    Patel SR; Lee LY; Mack CA; Polce DR; El-Sawy T; Hackett NR; Ilercil A; Jones EC; Hahn RT; Isom OW; Rosengart TK; Crystal RG
    Hum Gene Ther; 1999 May; 10(8):1331-48. PubMed ID: 10365664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of therapeutic angiogenesis from direct myocardial administration of an adenoviral vector expressing vascular endothelial growth factor 165.
    Zhang D; Gai L; Fan R; Dong W; Wen Y
    Chin Med J (Engl); 2002 May; 115(5):643-8. PubMed ID: 12133527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up assessment of a phase 1 trial of angiogenic gene therapy using direct intramyocardial administration of an adenoviral vector expressing the VEGF121 cDNA for the treatment of diffuse coronary artery disease.
    Rosengart TK; Bishawi MM; Halbreiner MS; Fakhoury M; Finnin E; Hollmann C; Shroyer AL; Crystal RG
    Hum Gene Ther; 2013 Feb; 24(2):203-8. PubMed ID: 23137122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic interleukin-6 responses following administration of adenovirus gene transfer vectors to humans by different routes.
    Ben-Gary H; McKinney RL; Rosengart T; Lesser ML; Crystal RG
    Mol Ther; 2002 Aug; 6(2):287-97. PubMed ID: 12349828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart.
    Mack CA; Patel SR; Schwarz EA; Zanzonico P; Hahn RT; Ilercil A; Devereux RB; Goldsmith SJ; Christian TF; Sanborn TA; Kovesdi I; Hackett N; Isom OW; Crystal RG; Rosengart TK
    J Thorac Cardiovasc Surg; 1998 Jan; 115(1):168-76; discussion 176-7. PubMed ID: 9451061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease.
    Symes JF; Losordo DW; Vale PR; Lathi KG; Esakof DD; Mayskiy M; Isner JM
    Ann Thorac Surg; 1999 Sep; 68(3):830-6; discussion 836-7. PubMed ID: 10509970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion.
    Mack CA; Magovern CJ; Budenbender KT; Patel SR; Schwarz EA; Zanzonico P; Ferris B; Sanborn T; Isom P; Ferris B; Sanborn T; Isom OW; Crystal RG; Rosengart TK
    J Vasc Surg; 1998 Apr; 27(4):699-709. PubMed ID: 9576084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve.
    Rajagopalan S; Shah M; Luciano A; Crystal R; Nabel EG
    Circulation; 2001 Aug; 104(7):753-5. PubMed ID: 11502697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for myocardial angiogenesis.
    Losordo DW; Vale PR; Isner JM
    Am Heart J; 1999 Aug; 138(2 Pt 2):S132-41. PubMed ID: 10426872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic angiogenesis with the use of vascular endothelial growth factor 165 gene in the myocardium of miniature swine].
    Zhang DZ; Gai LY; Chen YW; Fan RY; Wen YF; Dong W
    Sheng Li Xue Bao; 2001 Jun; 53(3):183-7. PubMed ID: 12589401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy with adenovirus-mediated myocardial transfer of vascular endothelial growth factor 121 improves cardiac performance in a pacing model of congestive heart failure.
    Leotta E; Patejunas G; Murphy G; Szokol J; McGregor L; Carbray J; Hamawy A; Winchester D; Hackett N; Crystal R; Rosengart T
    J Thorac Cardiovasc Surg; 2002 Jun; 123(6):1101-13. PubMed ID: 12063456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia.
    Losordo DW; Vale PR; Symes JF; Dunnington CH; Esakof DD; Maysky M; Ashare AB; Lathi K; Isner JM
    Circulation; 1998 Dec 22-29; 98(25):2800-4. PubMed ID: 9860779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous surgical revascularization and angiogenic gene therapy in diffuse coronary artery disease.
    Huwer H; Welter C; Ozbek C; Seifert M; Straub U; Greilach P; Kalweit G; Isringhaus H
    Eur J Cardiothorac Surg; 2001 Dec; 20(6):1128-34. PubMed ID: 11717016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.
    Harvey BG; Hackett NR; El-Sawy T; Rosengart TK; Hirschowitz EA; Lieberman MD; Lesser ML; Crystal RG
    J Virol; 1999 Aug; 73(8):6729-42. PubMed ID: 10400771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis.
    Lazarous DF; Shou M; Stiber JA; Hodge E; Thirumurti V; Gonçalves L; Unger EF
    Cardiovasc Res; 1999 Nov; 44(2):294-302. PubMed ID: 10690306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results.
    Lathi KG; Vale PR; Losordo DW; Cespedes RM; Symes JF; Esakof DD; Maysky M; Isner JM
    Anesth Analg; 2001 Jan; 92(1):19-25. PubMed ID: 11133594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia.
    Vale PR; Losordo DW; Milliken CE; Maysky M; Esakof DD; Symes JF; Isner JM
    Circulation; 2000 Aug; 102(9):965-74. PubMed ID: 10961959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.